ISSCR Opposes U.S. Restrictions on Fetal Tissue, Embryonic Stem Cell Research
The ISSCR joined with more than 60 medical, patient, and academic groups in writing a letter to the U.S. Senate to oppose prohibitions or restrictions that would further impede the use of federal funding for fetal tissue or embryonic stem cell research.
Addressed to leaders of the U.S. Senate Committee on Appropriations and the Subcommittee on the Departments of Labor, Health and Human Services, and Education, the letter describes the critical role that fetal tissue has played in scientific and medical advances, the devastating impact that restricting this research would have, and the well-established, rigorous oversight and regulatory framework currently in place.
Read the full letter, sent to U.S. Senate leadership in August, 2017.
Addressed to leaders of the U.S. Senate Committee on Appropriations and the Subcommittee on the Departments of Labor, Health and Human Services, and Education, the letter describes the critical role that fetal tissue has played in scientific and medical advances, the devastating impact that restricting this research would have, and the well-established, rigorous oversight and regulatory framework currently in place.
Read the full letter, sent to U.S. Senate leadership in August, 2017.